AT348981B - Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze - Google Patents

Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze

Info

Publication number
AT348981B
AT348981B AT180277A AT180277A AT348981B AT 348981 B AT348981 B AT 348981B AT 180277 A AT180277 A AT 180277A AT 180277 A AT180277 A AT 180277A AT 348981 B AT348981 B AT 348981B
Authority
AT
Austria
Prior art keywords
sulfonamido
amino
new
production
benzoic acid
Prior art date
Application number
AT180277A
Other languages
English (en)
Other versions
ATA180277A (de
Inventor
Judit Dr Kosary
Endre Dr Kasztreiner
Zsuzsa Dr Huszti
Agnes Kenessey
Gyoergy Dr Cseh
Veronika Szilagyi
Judit Stverteczky
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU76GO00001334A external-priority patent/HU172949B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA180277A publication Critical patent/ATA180277A/de
Application granted granted Critical
Publication of AT348981B publication Critical patent/AT348981B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT180277A 1976-03-18 1977-03-16 Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze AT348981B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762611705 DE2611705A1 (de) 1976-03-18 1976-03-18 N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel
HU76GO00001334A HU172949B (hu) 1976-03-18 1976-03-18 Sposob poluchenija novykh proizvodnykh sul'fonamido-benzojnoj kisloty

Publications (2)

Publication Number Publication Date
ATA180277A ATA180277A (de) 1978-08-15
AT348981B true AT348981B (de) 1979-03-12

Family

ID=25770228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT180277A AT348981B (de) 1976-03-18 1977-03-16 Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze

Country Status (9)

Country Link
US (1) US4244871A (de)
JP (1) JPS52136146A (de)
AT (1) AT348981B (de)
CA (1) CA1092111A (de)
DE (2) DE2611705A1 (de)
FR (1) FR2344531A1 (de)
GB (1) GB1561243A (de)
NL (1) NL7702991A (de)
SE (1) SE7703068L (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192820A (ja) * 1982-05-06 1983-11-10 Mochida Pharmaceut Co Ltd 抗ウイルス作用を有する医薬組成物
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
JPS61134382A (ja) * 1984-12-04 1986-06-21 Kyorin Pharmaceut Co Ltd 新規なスルファモイル安息香酸誘導体およびその製造法
JP2001508811A (ja) * 1998-04-20 2001-07-03 藤沢薬品工業株式会社 cGMP−ホスホジエステラーゼ阻害剤としてのアントラニル酸誘導体
CN100522171C (zh) * 2003-09-09 2009-08-05 弗·哈夫曼-拉罗切有限公司 作为甘氨酸摄取抑制剂、用于治疗精神病的1-苯甲酰基哌嗪衍生物
BRPI0414209B8 (pt) * 2003-09-09 2021-05-25 Hoffmann La Roche derivados de 1-(2-amino-benzol)-piperazina, seus processos de preparação e seu uso, e medicamento
DE602005014274D1 (de) * 2004-12-09 2009-06-10 Hoffmann La Roche Phenylpiperazin-methanon-derivate
ATE457989T1 (de) * 2004-12-15 2010-03-15 Hoffmann La Roche Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
US7485637B2 (en) * 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
MX2007008189A (es) * 2005-01-07 2007-08-07 Hoffmann La Roche Derivados de [4-(heteroaril)piperazin-1-il]-(fenilo 2,5-sustituido) metanona como inhibidores del transportador de glicina 1(glyt-1) para el tratamiento de trastornos neurologicos y neuropsiquiatricos.
CA2601326A1 (en) * 2005-01-18 2006-07-27 F.Hoffmann-La Roche Ag 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders
DE602006010175D1 (de) * 2005-01-26 2009-12-17 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
PT1848694E (pt) * 2005-02-07 2010-02-02 Hoffmann La Roche Fenil-metanonas heterocíclicas substituídas, como inibidores do transportador de glicina 1
GB0505086D0 (en) * 2005-03-11 2005-04-20 Glaxo Group Ltd Compounds
JP2011527345A (ja) * 2008-07-07 2011-10-27 ファスジェン, インコーポレイテッド 新規な化合物、この化合物を含む医薬組成物、この化合物の使用方法、およびこの化合物の調製方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2910488A (en) * 1958-01-22 1959-10-27 Merck & Co Inc Aniline derivatives
US3346568A (en) * 1961-09-14 1967-10-10 Ciba Geigy Corp 2-amino-5-sulfamyl-benzoic acid hydrazides
FR1403935A (fr) * 1963-06-05 1965-06-25 Ciba Geigy Nouveaux amides d'acides anthraniliques
US3839321A (en) * 1966-07-21 1974-10-01 Smithkline Corp 5-sulfamoyl-n-(2-substituted-ethyl) anthranilic acids
US3522274A (en) * 1967-05-24 1970-07-28 American Home Prod 2,3-dihydro-1-alkyl-7-sulfamoyl-4,1-benzoxazepin-5(1h)-ones
US3843662A (en) * 1971-12-09 1974-10-22 Pfizer 2-halo-5-(substituted piperidino sulfonyl)benzoic acids
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate
DE2423847A1 (de) * 1973-05-28 1975-01-02 Ciba Geigy Ag Neue sulfamoylbenzoesaeureamide
CH590262A5 (de) * 1973-07-10 1977-07-29 Ciba Geigy Ag

Also Published As

Publication number Publication date
DE2611705A1 (de) 1977-09-22
FR2344531B1 (de) 1980-04-04
GB1561243A (en) 1980-02-13
SE7703068L (sv) 1977-09-19
NL7702991A (nl) 1977-09-20
DE2712023A1 (de) 1977-10-06
FR2344531A1 (fr) 1977-10-14
CA1092111A (en) 1980-12-23
JPS52136146A (en) 1977-11-14
US4244871A (en) 1981-01-13
ATA180277A (de) 1978-08-15

Similar Documents

Publication Publication Date Title
ATA630875A (de) Verfahren zur herstellung neuer derivate der 3-chinolincarbonsaure sowie ihrer saureadditionssalze
AT367418B (de) Verfahren zur herstellung neuer tetrahydropyridinylindolderivate und ihrer salze
ATA922877A (de) Verfahren zur herstellung von neuen ver- aetherten cyclopentan-1-aminen sowie deren salzen
AT294108B (de) Verfahren zur Herstellung neuer Benzamidoäthylpiperazine sowie ihrer Säureadditionssalze
AT348981B (de) Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze
AT366682B (de) Verfahren zur herstellung neuer 3-fluor-6piperazinylmorphanthridine und ihrer saeureadditionssalze
AT363474B (de) Verfahren zur herstellung neuer carbostyrilderivate und ihrer pharmazeutisch geeigneten saeureadditionssalze
AT350737B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
AT370421B (de) Verfahren zur herstellung von alkaloiden des leurosin-typs sowie von deren salzen
AT347451B (de) Verfahren zur herstellung neuer 2-acetylamino- thiazolderivate sowie ihrer saeureadditions- salze
AT349020B (de) Verfahren zur herstellung neuer 3,4- dihydrocarbostyril-derivate und ihrer saeureadditonssalze
ATA342176A (de) Verfahren zur herstellung neuer 2-imidazolyl- chinazoline und ihrer salze
AT368993B (de) Verfahren zur herstellung neuer 4-hydroxy-2chinolinon-3-carbonsaeureester und ihrer pharmazeutisch vertraeglichen salze
AT377256B (de) Verfahren zur herstellung neuer 1-phenaethylimidazol-derivate und ihrer saeureadditionssalze
AT351020B (de) Verfahren zur herstellung neuer 4-phenyl- imidazoline und ihrer saeureadditionssalze
ATA67677A (de) Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze
AT347960B (de) Verfahren zur herstellung neuer hydrazinopyri- dazinderivate und deren salzen
AT348984B (de) Verfahren zur herstellung neuer omega- aminoalkoxyalkane und ihrer salze
ATA39976A (de) Verfahren zur herstellung neuer 2-6-bis- (aminoacylamino) -anthrachinone sowie ihrer saureadditionssalze
AT352713B (de) Verfahren zur herstellung neuer 1-azidoalkyl- imidazole und ihrer saeureadditionssalze
ATA269779A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
ATA8579A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT350519B (de) Verfahren zur herstellung von neuen omega- amino-alkoxycycloalkanen sowie deren saeure- additonssalzen
ATA799175A (de) Verfahren zur herstellung neuer thiazol-5-carbonsaurederivate und ihrer salze
ATA189379A (de) Verfahren zur herstellung neuer imidazol- derivate und ihrer salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties